Search Results - Ken Inada

Refine Results
  1. 1

    Asenapine versus olanzapine for the treatment of nausea and vomiting in patients with cancer: A retrospective study by Tomohiko Kimura, Akifumi Kanai, Hiroyuki Muraoka, Yuichiro Takahashi, Masatomo Ara, Ken Inada

    Published in Neuropsychopharmacology Reports (2024-03-01)
    Get full text
    Article


  2. 2

    Role of Serum Lithium Concentrations in Predicting Hyperparathyroidism and Hypercalcemia by Noriyoshi Takano, Satoshi Morimoto, Hiroyuki Muraoka, Ken Inada, Katsuji Nishimura, Atsuhiro Ichihara

    Published in International Journal of Endocrinology (2025-01-01)
    Get full text
    Article


  3. 3

    Patterns of hypnotic prescribing for residual insomnia and recurrence of major depressive disorder: a retrospective cohort study using a Japanese health insurance claims database by Kentaro Yamato, Ken Inada, Minori Enomoto, Tatsuro Marumoto, Masahiro Takeshima, Kazuo Mishima

    Published in BMC Psychiatry (2021-01-01)
    Get full text
    Article


  4. 4

    Stigmatized attitudes of medical staff toward people who use drugs and their determinants in Japanese medical facilities specialized in addiction treatment by Munenori Katayama, So Fujishiro, Kanna Sugiura, Jun Konishi, Ken Inada, Norihito Shirakawa, Toshihiko Matsumoto

    Published in Neuropsychopharmacology Reports (2023-12-01)
    Get full text
    Article


  5. 5

    Factors associated with death, hospitalization, resignation, and sick leave from work among patients with schizophrenia in Japan: a nested case–control study using a large claims d... by Ken Inada, Yoshitaka Saito, Kenji Baba, Daisuke Fukui, Yuriko Masuda, Sachie Inoue, Takahiro Masuda

    Published in BMC Psychiatry (2024-01-01)
    Get full text
    Article


  6. 6

    Greater impact of COVID‐19 on peer‐supported addiction services than government‐owned services for addiction in Japan: A nationwide 3‐year longitudinal cohort study by Munenori Katayama, Sou Fujishiro, Kanna Sugiura, Jun Konishi, Ken Inada, Norihito Shirakawa, Toshihiko Matsumoto

    Published in PCN Reports (2024-12-01)
    Get full text
    Article


  7. 7

    Factors influencing stigma among healthcare professionals towards people who use illicit drugs in Japan: A quantitative study by Munenori Katayama, Kanna Sugiura, So Fujishiro, Jun Konishi, Ken Inada, Norihito Shirakawa, Toshihiko Matsumoto

    Published in PCN Reports (2023-09-01)
    Get full text
    Article


  8. 8

    Secondary Publication: Mental Health Care on COVID-19 Pandemic: The Role of Psychiatric Team on Pandemic by Kosuke Takano, Ken Inada, Hiroyuki Muraoka, Atsuko Inoue, Taeko Yasuda, Rie Akaho, Katsuji Nishimura

    Published in Tokyo Women's Medical University Journal (2021-07-01)
    Get full text
    Article


  9. 9

    Comparison of Efficacies of a Blonanserin Transdermal Patch and Blonanserin Oral Formulation for Psychiatric Symptoms in Patients With Schizophrenia Treated With Laxatives Using a... by Ken Inada, Hiroyuki Muraoka, Yuji Matsumoto, Daisuke Fukui, Tomomi Watanabe, Yuriko Masuda, Sachie Inoue, Takahiro Masuda

    Published in Neuropsychopharmacology Reports (2025-03-01)
    Get full text
    Article


  10. 10

    Effects of chronic haloperidol treatment on the expression of fear memory and fear memory extinction in the cued fear‐conditioned rats by Kosuke Enomoto, Kazuro Shibata, Hiroyuki Muraoka, Masahiko Kawano, Ken Inada, Jun Ishigooka, Katsuji Nishimura, Hidehiro Oshibuchi

    Published in Neuropsychopharmacology Reports (2024-03-01)
    Get full text
    Article


  11. 11

    An association between cancer type and delirium incidence in Japanese elderly patients: A retrospective longitudinal study by Kentaro Yamato, Ai Ikeda, Motoki Endo, Ronald Filomeno, Kosuke Kiyohara, Ken Inada, Katsuji Nishimura, Takeshi Tanigawa

    Published in Cancer Medicine (2023-02-01)
    Get full text
    Article


  12. 12

    A Longitudinal Study of the Association of Blood Unsaturated Fatty Acids With Posttraumatic Stress Disorder (PTSD) by Tomoko Inoue, Shintaro Ogawa, Zui Narita, Masayuki Sekiguchi, Yasushi Asari, Yuichi Kataoka, Jun Hattori, Hiroaki Hori, Yoshiharu Kim, Ken Inada

    Published in Neuropsychopharmacology Reports (2025-03-01)
    Get full text
    Article


  13. 13

    Effect of intermittent subchronic MK‐801 administration on dopamine synthesis capacity and responsiveness in the prefrontal cortex by Kazuro Shibata, Kosuke Enomoto, Takahiro Tsutsumi, Hiroyuki Muraoka, Tatsu Fuwa, Masahiko Kawano, Jun Ishigooka, Ken Inada, Katsuji Nishimura, Hidehiro Oshibuchi

    Published in Neuropsychopharmacology Reports (2024-06-01)
    Get full text
    Article


  14. 14

    Impact of psychotropic pro re nata prescription-monitoring programme on prescriptions for inpatients with psychiatric disorders: a retrospective observational study by Yoshitaka Saito, Kyohei Sumida, Hiroyuki Muraoka, Satoru Oishi, Ryutaro Suzuki, Taiyo Nishikawa, Shin Miyake, Yukihiro Tanno, Yuki Tobita, Katsuya Otori, Ken Inada

    Published in BMC Psychiatry (2025-01-01)
    Get full text
    Article


  15. 15

    The impact of the number of non-opioid psychotropic medications and their co-exposures during pregnancy on short-term outcomes in full-term neonates by Hitoshi Isohata, Sumie Miura, Yu Yamazaki, Hiroyuki Goto, Yoshihiro Yoshimura, Kyoko Hattori, Takao Shimaoka, Kazuki Sekiguchi, Hidehiko Nakanishi, Ken Inada, Daigo Ochiai

    Published in Scientific Reports (2025-08-01)
    Get full text
    Article


  16. 16

    Development and acceptability of a decision aid for anxiety disorder considering discontinuation of benzodiazepine anxiolytic by Yumi Aoki, Yumi Aoki, Yoshikazu Takaesu, Yoshikazu Takaesu, Ken Inada, Hiroki Yamada, Tomohiko Murao, Toshiaki Kikuchi, Masahiro Takeshima, Masayuki Tani, Kazuo Mishima, Tempei Otsubo

    Published in Frontiers in Psychiatry (2023-05-01)
    Get full text
    Article


  17. 17

    Development and acceptability testing of a decision aid for considering whether to reduce antipsychotics in individuals with stable schizophrenia by Yumi Aoki, Yoshikazu Takaesu, Kentaro Matsui, Takahiro Tokumasu, Hideaki Tani, Yoshiteru Takekita, Tetsufumi Kanazawa, Taishiro Kishimoto, Seiichiro Tarutani, Naoki Hashimoto, Hiroyoshi Takeuchi, Kazuo Mishima, Ken Inada

    Published in Neuropsychopharmacology Reports (2023-09-01)
    Get full text
    Article


  18. 18

    Development, reliability, and validity of the quality of life scale for insomnia: a health-related quality of life instrument for insomnia by Naoko Ayabe, Naoko Ayabe, Isa Okajima, Isa Okajima, Wataru Yamadera, Hisateru Tachimori, Hisateru Tachimori, Hidehisa Yamashita, Naohisa Uchimura, Ken Inada, Yuichi Inoue, Kazuo Mishima, Kazuo Mishima

    Published in Frontiers in Psychiatry (2025-05-01)
    Get full text
    Article


  19. 19

    Management of unspecified anxiety disorder: Expert consensus by Hitoshi Sakurai, Ken Inada, Yumi Aoki, Masahiro Takeshima, Kenya Ie, Morito Kise, Eriko Yoshida, Takashi Tsuboi, Hisashi Yamada, Hikaru Hori, Yasushi Inada, Eiji Shimizu, Kazuo Mishima, Koichiro Watanabe, Yoshikazu Takaesu

    Published in Neuropsychopharmacology Reports (2023-06-01)
    Get full text
    Article


  20. 20

    Clinical practice for unspecified anxiety disorder in primary care by Hitoshi Sakurai, Masahiro Takeshima, Ken Inada, Yumi Aoki, Kenya Ie, Morito Kise, Eriko Yoshida, Takashi Tsuboi, Hisashi Yamada, Hikaru Hori, Yasushi Inada, Eiji Shimizu, Kazuo Mishima, Koichiro Watanabe, Yoshikazu Takaesu

    Published in PCN Reports (2023-09-01)
    Get full text
    Article


Search Tools: